Analysts Set CVS Health Corporation (NYSE:CVS) PT at $75.38

CVS Health Corporation (NYSE:CVSGet Free Report) has earned a consensus rating of “Moderate Buy” from the twenty ratings firms that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $75.38.

Several brokerages have recently issued reports on CVS. Wall Street Zen raised CVS Health from a “hold” rating to a “buy” rating in a research note on Friday, May 9th. Piper Sandler upped their price objective on CVS Health from $72.00 to $74.00 and gave the company an “overweight” rating in a report on Friday, March 21st. Cowen restated a “buy” rating on shares of CVS Health in a report on Monday, May 5th. Morgan Stanley restated an “overweight” rating on shares of CVS Health in a report on Tuesday, April 15th. Finally, Mizuho raised their price objective on CVS Health from $70.00 to $76.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 9th.

Check Out Our Latest Stock Analysis on CVS Health

CVS Health Stock Performance

Shares of NYSE CVS opened at $63.34 on Friday. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77. The business’s 50 day moving average is $64.80 and its two-hundred day moving average is $62.76. The company has a market cap of $80.13 billion, a P/E ratio of 15.12, a P/E/G ratio of 0.91 and a beta of 0.57. CVS Health has a 12 month low of $43.56 and a 12 month high of $72.51.

CVS Health (NYSE:CVSGet Free Report) last announced its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The firm had revenue of $94.59 billion for the quarter, compared to analysts’ expectations of $93.07 billion. During the same period in the prior year, the business posted $1.31 earnings per share. The business’s revenue was up 7.0% compared to the same quarter last year. On average, equities analysts expect that CVS Health will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.20%. The ex-dividend date is Tuesday, July 22nd. CVS Health’s dividend payout ratio (DPR) is presently 63.48%.

Insider Buying and Selling

In other CVS Health news, Director Guy P. Sansone acquired 1,570 shares of the business’s stock in a transaction dated Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the transaction, the director directly owned 12,007 shares in the company, valued at approximately $764,845.90. The trade was a 15.04% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.22% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Bell Investment Advisors Inc lifted its stake in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 248 shares in the last quarter. McIlrath & Eck LLC raised its position in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 174 shares in the last quarter. Roxbury Financial LLC grew its holdings in CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares during the last quarter. ORG Partners LLC grew its holdings in CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares during the last quarter. Finally, Saudi Central Bank bought a new position in CVS Health during the 1st quarter valued at about $34,000. Institutional investors own 80.66% of the company’s stock.

About CVS Health

(Get Free Report

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Further Reading

Analyst Recommendations for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.